Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

CyberKnife radiosurgery is a 15-minute outpatient procedure that requires no anesthesia or hospital admission, offering a non ...

Magnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...

The Vattikuti Foundation has donated a state-of-the-art Insightec MR-Guided HIFU system to AIIMS, along with five years of ...

Alum, Faculty of Science > Co-founder and CEO of Foqus Technologies Current magnetic resonance imaging (MRI) machines ...

A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...

Thanks to its capacity to detect patterns and stay consistent, machine learning is a great tool for CNS behaviour studies.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...